Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006508
Filing Date
2024-08-26
Accepted
2024-08-26 16:25:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3326
  Complete submission text file 0001950047-24-006508.txt   4806
Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 144

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Subject) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39460 | Film No.: 241241702
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)